TR200100290T2 - Estradiol-containing patch for transdermal hormone administration - Google Patents

Estradiol-containing patch for transdermal hormone administration

Info

Publication number
TR200100290T2
TR200100290T2 TR2001/00290T TR200100290T TR200100290T2 TR 200100290 T2 TR200100290 T2 TR 200100290T2 TR 2001/00290 T TR2001/00290 T TR 2001/00290T TR 200100290 T TR200100290 T TR 200100290T TR 200100290 T2 TR200100290 T2 TR 200100290T2
Authority
TR
Turkey
Prior art keywords
estradiol
active ingredient
containing patch
hormone administration
transdermal hormone
Prior art date
Application number
TR2001/00290T
Other languages
Turkish (tr)
Inventor
Kirstgen Elvira
Meconi Reinhold
Original Assignee
Lts Lohmann Therapie-Systeme Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lts Lohmann Therapie-Systeme Ag filed Critical Lts Lohmann Therapie-Systeme Ag
Publication of TR200100290T2 publication Critical patent/TR200100290T2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/20—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing organic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/58—Adhesives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34—Gestagens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Materials Engineering (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)

Abstract

Estradiolün veya eczacilik açisindan sakinca olusturmayan türevlerinin tek basina veya Gestajenler ile kombinasyon halinde insan veya hayvan cildine kontrollü olarak verilmesi için, bir arka tabakandan, tutucu yapistiricilar kullanilarak imal edilen ve etki maddesinin kombinasyon halinde verilmesine uygun, etki maddesi içeren buna bagli bir rezervuardan ve tekrar çikarilabilen bir koruyucu tabakadan ibaret olan etki maddesi içerikli flasterin özelligi, tutucu yapistiricinin kolesterol veya misir nisastasi içermesidir.For the administration of estradiol or its non-pharmaceutically derived derivatives in a controlled manner to human or animal skin alone or in combination with Gestagens, it can be removed from a backsheet, a retaining reservoir containing the active ingredient containing it and suitable for the combination of the active ingredient and can be removed. The active ingredient-containing patch, which consists of a protective layer, is characterized in that the holding adhesive contains cholesterol or corn starch.

TR2001/00290T 1998-07-29 1999-07-16 Estradiol-containing patch for transdermal hormone administration TR200100290T2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19834006A DE19834006A1 (en) 1998-07-29 1998-07-29 Estradiol-containing patch for the transdermal application of hormones

Publications (1)

Publication Number Publication Date
TR200100290T2 true TR200100290T2 (en) 2001-07-23

Family

ID=7875612

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/00290T TR200100290T2 (en) 1998-07-29 1999-07-16 Estradiol-containing patch for transdermal hormone administration

Country Status (14)

Country Link
EP (1) EP1100478A1 (en)
JP (1) JP2002521426A (en)
KR (1) KR20010072071A (en)
CN (1) CN1310615A (en)
AR (1) AR019948A1 (en)
AU (1) AU762589B2 (en)
BR (1) BR9912688A (en)
CA (1) CA2338861A1 (en)
DE (1) DE19834006A1 (en)
IL (1) IL141032A0 (en)
PL (1) PL345696A1 (en)
TR (1) TR200100290T2 (en)
WO (1) WO2000006130A1 (en)
ZA (1) ZA200100721B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005047906A (en) * 2003-07-16 2005-02-24 Taisho Pharmaceut Co Ltd Anti-inflammatory/analgesic composition for external application
KR100689534B1 (en) * 2005-05-18 2007-03-02 삼성전자주식회사 Mobile phone

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH674618A5 (en) * 1987-04-02 1990-06-29 Ciba Geigy Ag
DE4210711A1 (en) * 1991-10-31 1993-05-06 Schering Ag Berlin Und Bergkamen, 1000 Berlin, De TRANSDERMAL THERAPEUTIC SYSTEMS WITH CRYSTALIZATION INHIBITORS
US5676968A (en) * 1991-10-31 1997-10-14 Schering Aktiengesellschaft Transdermal therapeutic systems with crystallization inhibitors
DE4229820C2 (en) * 1992-09-07 1998-12-03 Jenapharm Gmbh Progestogen-based pharmaceutical preparation
WO1995017896A1 (en) * 1993-12-27 1995-07-06 Akzo Nobel N.V. Percutaneously absorbable preparation
DE4416927C1 (en) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Device for release of active agents from melt-type adhesive

Also Published As

Publication number Publication date
JP2002521426A (en) 2002-07-16
AU5284299A (en) 2000-02-21
ZA200100721B (en) 2002-05-27
IL141032A0 (en) 2002-02-10
CN1310615A (en) 2001-08-29
DE19834006A1 (en) 2000-02-24
PL345696A1 (en) 2002-01-02
BR9912688A (en) 2001-11-27
AU762589B2 (en) 2003-06-26
CA2338861A1 (en) 2000-02-10
KR20010072071A (en) 2001-07-31
WO2000006130A1 (en) 2000-02-10
EP1100478A1 (en) 2001-05-23
AR019948A1 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
TR200100289T2 (en) Estradiol-containing patch for transdermal hormone administration
DK0744944T3 (en) Transdermal therapeutic systems containing genital periods
ATE238778T1 (en) TRANSDERMAL THERAPEUTIC SYSTEM FOR THE RELEASE OF HORMONES
TR27992A (en) Silicone-suspended thermoplastic elastomeric copolymers that can be dissolved or dispersed in water or alcohol, and sheet and skin care compositions containing them.
TR200100022T2 (en) Local acting patch containing non-steroidal acid group rheumatic drug
MY106628A (en) Estrogen-containing active substance plaster
AU4923500A (en) Device and method for increasing the transdermal permeation of medicaments
PL335446A1 (en) Transcutaneous therapeutic system
NO950051L (en) Patch for low-melting and / or volatile active ingredients
DK0802789T3 (en) Estradiol-containing patch
KR950703972A (en) TRANSADERMAL ADMINISTRATION SYSTEM CONTAINING ACETYLSALICYLIIC ACID FOR ANTITHROMBOTIC THERAPY AND THE PREVENTION OF CANCER
PL307786A1 (en) Plaster for percutaneous administration of systemically acting steroid hormones
AU2003215657A1 (en) Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion.
JP2004500353A5 (en)
JP2002521427A5 (en)
TR200100290T2 (en) Estradiol-containing patch for transdermal hormone administration
ATE214606T1 (en) TRANSDERMAL THERAPEUTIC SYSTEM WITH THE ACTIVE INGREDIENT SCOPOLAMIN BASE
GB1292545A (en) Medical plaster
EP0991404A1 (en) Device for delivery of dermatological ingredients
YU71293A (en) TRANSDERMAL THERAPY SYSTEM FOR THE PROMOTION OF PHYSOSTIGMIN ON THE SKIN AND THE PROCEDURE FOR ITS MAKING
AR020108A1 (en) PREPARED FOR THE PERCUTANEOUS THERAPEUTIC APPLICATION OF GLICEROL TRINITRATE, A PROCEDURE FOR ITS PREPARATION AND EMPLOYMENT
BR0302225A (en) Application for aromatase inhibitors or estradiol receptor blockers and their derivatives in the treatment of chloasma and melasma in humans
Holley Making it love
AR024199A1 (en) USE OF BUPRENORFINE IN THE PREPARATION OF A TRANSDERMAL SUPPLY DEVICE